Skip to main navigation

Terms and Conditions

*

Client nav

About Arcturus

RNA Medicines

Technologies

Pipeline

Business Development

Publications

Investor Relations

Press Releases

Year:

Items per page

October 31, 2017 at 12:00 AM EDT

Summary Toggle Arcturus Therapeutics and Synthetic Genomics Announce Strategic Alliance to Develop Next-Generation Vaccines and Therapeutics

SAN DIEGO, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Arcturus Therapeutics, Inc., a leading RNA medicines company, and Synthetic Genomics, Inc. announced today that they have entered into a research collaboration and worldwide license agreement to develop self-amplifying RNA-based vaccines and therapeutics

PDF Version
October 26, 2017 at 11:22 AM EDT

Summary Toggle Arcturus Therapeutics Announces Presentations at Conferences in November

PDF Version
October 19, 2017 at 12:00 AM EDT

Summary Toggle Arcturus Therapeutics Announces Strategic Collaboration with Johnson & Johnson Innovation to Discover and Develop RNA Medicines

SAN DIEGO, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Arcturus Therapeutics, Inc., a leading RNA medicines company, announced today that it has entered into a research collaboration and worldwide license agreement with Janssen Pharmaceuticals, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of

PDF Version
October 6, 2017 at 11:40 PM EDT

Summary Toggle Arcturus Therapeutics, Inc. to Present at the Chardan Gene Therapy Conference

PDF Version
September 27, 2017 at 11:42 AM EDT

Summary Toggle Alcobra Ltd. and Arcturus Therapeutics, Inc. Agree to Merge

PDF Version
May 30, 2017 at 11:44 AM EDT

Summary Toggle Arcturus Therapeutics to Receive Up to $3 Million from Cystic Fibrosis Foundation Therapeutics to Advance a Novel LUNAR-Formulated mRNA CFTR Therapeutic

PDF Version
May 29, 2017 at 11:46 AM EDT

Summary Toggle Boston CEO Conference-Panel Discussion on Advances in Personalized Medicine

PDF Version
May 15, 2017 at 11:50 AM EDT

Summary Toggle Ernst & Young Selected Arcturus as the Finalists for the Entrepreneur Of The Year 2017 Award® in San Diego
April 10, 2017 at 11:54 AM EDT

Summary Toggle Arcturus Therapeutics is Selected by Ernst and Young as Semifinalists for the Entrepreneur Of The Year® 2017 Award in San Diego
December 6, 2016 at 12:18 PM EST

Summary Toggle Arcturus Therapeutics Announces Collaboration with Takeda Pharmaceuticals to Develop RNA–based Therapeutics for the Treatment of Nonalcoholic Steatohepatitis (NASH)

PDF Version

Pagination

First page
Previous page
…
Page 20
Current page 21
Page 22
Page 23
…
Next page
Last page

Displaying 201 - 210 of 240 results

Investor Home

Corporate Governance

Governance Highlights
Management Team
Board of Directors
Committee Composition

Financials & Filings

SEC Filings
Annual Reports
Quarterly Results

News & Events

Press Releases
Videos
Media Coverage
Presentations
Events

Stock Information

Stock Quote
Historical Price Lookup
Analyst Coverage

Investor Resources

Investor FAQ
Contact IR
Email Alerts

Home
Contact
Careers
Terms and Conditions
Privacy Policy

© 2024 Arcturus Therapeutics, Inc.

Search